Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009771', 'term': 'Obsessive-Compulsive Disorder'}, {'id': 'D001008', 'term': 'Anxiety Disorders'}, {'id': 'D003863', 'term': 'Depression'}], 'ancestors': [{'id': 'D001523', 'term': 'Mental Disorders'}, {'id': 'D001526', 'term': 'Behavioral Symptoms'}, {'id': 'D001519', 'term': 'Behavior'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D017367', 'term': 'Selective Serotonin Reuptake Inhibitors'}, {'id': 'D004358', 'term': 'Drug Therapy'}, {'id': 'D015928', 'term': 'Cognitive Behavioral Therapy'}, {'id': 'D011613', 'term': 'Psychotherapy'}, {'id': 'D009147', 'term': 'Music Therapy'}], 'ancestors': [{'id': 'D014179', 'term': 'Neurotransmitter Uptake Inhibitors'}, {'id': 'D049990', 'term': 'Membrane Transport Modulators'}, {'id': 'D045504', 'term': 'Molecular Mechanisms of Pharmacological Action'}, {'id': 'D020228', 'term': 'Pharmacologic Actions'}, {'id': 'D020164', 'term': 'Chemical Actions and Uses'}, {'id': 'D018377', 'term': 'Neurotransmitter Agents'}, {'id': 'D018490', 'term': 'Serotonin Agents'}, {'id': 'D045505', 'term': 'Physiological Effects of Drugs'}, {'id': 'D013812', 'term': 'Therapeutics'}, {'id': 'D001521', 'term': 'Behavior Therapy'}, {'id': 'D004191', 'term': 'Behavioral Disciplines and Activities'}, {'id': 'D026421', 'term': 'Sensory Art Therapies'}, {'id': 'D000529', 'term': 'Complementary Therapies'}, {'id': 'D012046', 'term': 'Rehabilitation'}, {'id': 'D000359', 'term': 'Aftercare'}, {'id': 'D003266', 'term': 'Continuity of Patient Care'}, {'id': 'D005791', 'term': 'Patient Care'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 30}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2014-04'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2014-12', 'completionDateStruct': {'date': '2014-08', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2014-12-10', 'studyFirstSubmitDate': '2014-11-27', 'studyFirstSubmitQcDate': '2014-12-10', 'lastUpdatePostDateStruct': {'date': '2014-12-11', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2014-12-11', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2014-06', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Obsession (Maudsley Obsessive-Compulsive Inventory)', 'timeFrame': '1 month', 'description': 'Post-intervention scores on Maudsley Obsessive-Compulsive Inventory'}], 'secondaryOutcomes': [{'measure': 'Obsession subtype (Maudsley Obsessive-Compulsive Inventory sub-types)', 'timeFrame': '1 month', 'description': 'Post-intervention scores on Maudsley Obsessive-Compulsive Inventory sub-types'}, {'measure': 'Anxiety symptoms (Beck Anxiety Inventory)', 'timeFrame': '1 month', 'description': 'Post-intervention scores on Beck Anxiety Inventory'}, {'measure': 'Depressive symptoms (Beck Depression Inventory - Short Form)', 'timeFrame': '1 month', 'description': 'Post-intervention scores on Beck Depression Inventory - Short Form'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Obsessive Compulsive Disorder', 'Music Therapy/methods', 'Combined Modality Therapy', 'Anxiety Disorders/therapy'], 'conditions': ['Obsessive-Compulsive Disorder', 'Anxiety', 'Depression']}, 'descriptionModule': {'briefSummary': 'Previous studies have highlighted the potential therapeutic benefits of receptive individual music therapy as an adjunct to standard care, in a variety of psychiatric ailments including mood and anxiety disorders. However, the role of music in the treatment of obsessive compulsive disorder have not been investigated to date. The present study therefore aimed to investigate the efficacy of music therapy as an adjunct to standard treatment, on obsessions in patients with treatment-naïve OCD. Moreover, given the fact that a significant proportion of patients with OCD have other comorbid mood or anxiety disorders, the question of whether therapeutic benefits of music could be expanded to also affect concurrent depressive and anxiety symptoms was explored.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* were at least 18 years or older;\n* had axis I diagnosis of OCD according to the criteria delineated by the diagnostic and statistical manual of mental disorders - fourth edition diagnosed by an experienced psychiatrist\n* had not received treatment previously for the disorder\n* agreed to partake in the study\n\nExclusion Criteria:\n\n* refused to partake in the study'}, 'identificationModule': {'nctId': 'NCT02314195', 'briefTitle': 'Music Therapy in Obsessive Compulsive Disorder', 'organization': {'class': 'OTHER', 'fullName': 'Islamic Azad University, Marvdasht'}, 'officialTitle': 'A Randomized Clinical Trial of Music Therapy as an Adjunct to Standard Treatment for Obsessive Compulsive Disorder and Co-morbid Anxiety and Depression in Iran', 'orgStudyIdInfo': {'id': '2172719'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Standard treatment + music therapy', 'description': 'Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy. Music therapy encompassing 12 half-hour sessions of therapist-supervised receptive music therapy scheduled over four weeks', 'interventionNames': ['Drug: Selective serotonin re-uptake inhibitor', 'Behavioral: Cognitive Behavioral Therapy', 'Other: Music therapy']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Standard treatment only', 'description': 'Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy.', 'interventionNames': ['Drug: Selective serotonin re-uptake inhibitor', 'Behavioral: Cognitive Behavioral Therapy']}], 'interventions': [{'name': 'Selective serotonin re-uptake inhibitor', 'type': 'DRUG', 'otherNames': ['Pharmacotherapy'], 'description': 'A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.', 'armGroupLabels': ['Standard treatment + music therapy', 'Standard treatment only']}, {'name': 'Cognitive Behavioral Therapy', 'type': 'BEHAVIORAL', 'otherNames': ['Psychotherapy'], 'description': 'Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.', 'armGroupLabels': ['Standard treatment + music therapy', 'Standard treatment only']}, {'name': 'Music therapy', 'type': 'OTHER', 'otherNames': ['Receptive music therapy'], 'description': '12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.', 'armGroupLabels': ['Standard treatment + music therapy']}]}, 'contactsLocationsModule': {'locations': [{'zip': '56465201', 'city': 'Isfahan', 'state': 'Isfahan', 'country': 'Iran', 'facility': 'Shariati Hospital', 'geoPoint': {'lat': 32.65246, 'lon': 51.67462}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Islamic Azad University, Marvdasht', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Shahrzad Shirani Bidabadi, M.S.c', 'investigatorFullName': 'Shahrzad Shirani', 'investigatorAffiliation': 'Islamic Azad University, Marvdasht'}}}}